期刊文献+

晚期鼻咽癌同期放化疗近期疗效临床研究 被引量:1

Clinical study on short-term efficacy of concomitant radiochemotherapy for patients with advanced nasopharyngeal carcinoma
下载PDF
导出
摘要 目的:观察晚期鼻咽癌同期放化疗的近期疗效,以便更好地开展鼻咽癌的临床工作。方法:晚期鼻咽癌80例按入院先后次序随机抽样分成2组,每组40例,做前瞻性研究,治疗组用放疗加化疗,对照组单用放疗,治疗过程中评价不良反应,治疗结束后4个月评价肿瘤消退情况及不良反应。结果:治疗组鼻咽部肿瘤消退率及颈淋巴结消退率明显高于对照组,治疗期间治疗组的不良反应高于对照组,治疗4个月不良反应两组无明显差别。结论:晚期鼻咽癌采用同期放化疗有更好的近期疗效,其不良反应也在可控范围内。 Objective:To observe the short-term efficacy in order to instruct the work about the advanced nasopharyngeal carcinoma (NPC) more effectively.Methods: 80 cases of advanced NPC were sampled randomly for the study,They were divided into 2 groups of 40 each and treated with different ways.Treatment group was used with chemotherapy plus radiotherapy,while control group with radiotherapy alone.The observation items were the regression of primary tumor and neck lymphnodes as well as the systematical and topical side effects.Results:The regression rate of treatment group was significantly higher than that of control group.The former had more side effects in the treatment,but 4 months later, the former had no difference from the latter in this aspect.Conclusion:The concomitant radiochemotherapy for advanced NPC showed a better short-term curative effects with some curable toxicities.
出处 《现代医药卫生》 2006年第10期1441-1442,共2页 Journal of Modern Medicine & Health
关键词 鼻咽癌 放化疗 不良反应 同期 Nasopharyngeal carcinoma Concomitant radio-chemotherapy Adverse reaction
  • 相关文献

参考文献4

  • 1谷铣之,殷蔚伯,刘泰福,等.肿癌放射治疗学[M].北京:北京医科大学中国协和医科大学联合出版社,1997,452.
  • 2Lin JC,Jan JS,Hsu CY,et al.Phase Ⅲ study of concurrent chemoradiotherapy versus radiotherapy alone for advanced nasopharyngeal carcinoma:positive effect on overall and progression-free survival[J].J Clin Oncol,2003,21 (4):631.
  • 3秦风展,陈振东,樊青霞,等.肿瘤内科治疗学-新理论、新观点、新技术[M].北京:人民军医出版社,2004.452.
  • 4姚鸿民,董燃.诱导化疗联合放疗治疗晚期鼻咽癌的临床研究[J].实用肿瘤学杂志,2002,16(2):143-144. 被引量:7

二级参考文献4

  • 1[1]Gcara FB, Glisson BS, Sanguineti G, et al. Induction chemotherapy followed by radiotherapy versus radiotherapy alone in patients with advanced nasopharyngeal carcinuma: results of a matched cohort study[J].Cancer, 1997;79(7): 1279 ~ 1286
  • 2[2]AL - Sarraf M, LeBlanc M, Giri PG, et al. Chemoradiotherapy versus radiotherapy in patients with advanced nasopharyngeal cancer: Phase Ⅲ randomized Intergroup study 0099[J]. J Clin Oncol, 1998; 16(4): 1310~ 1317
  • 3[3]Chua DT, Sham JS. Choy D, et al. Preliminary report of the AsianOceaninn Cinical Oncology Association randomized trial comparing cisplatin and epirubicin followed by radiotherapy versus radiotherapy alone in the treatment of patients with Iocoregionally advanced nasopharyngeal carcinoma. Asian- Oceanian clinical Oncology Association Nasopharynx Cancer Sudy Group[J].Caneer. 1998;83(11):2270~ 2283
  • 4[4]Chan AT, Teo PM, Lenug TW, et al. A prospective randomized study of chemotherapy adjunctive to definitive radiotherapy in advanced nasopharyngeal carcinoma [J] .Int J Radiat Oncol Biol Phys, 1995;33(3):569~577

共引文献6

同被引文献10

  • 1蔡永广,符爱珍,劳逸.新辅助化疗联合放疗治疗中晚期鼻咽癌的疗效观察[J].现代肿瘤医学,2007,15(2):187-189. 被引量:7
  • 2Cox JD, Stetz J, Pajak TF. Toxicity criteria of the radiation therapy oncology group(RTOG) and the european organization for research and treatment of cancer ( EORTC ) [ J ]. Int J Radiat Oncol Biol Phys,1995,31 (5) :1341-1346.
  • 3Chua DT, Sham JS, Choy D, et al. Preliminary report of the asian-o- ceanian clinical oncology association randomized trial comparing cisplatin and eprirubicin followed by radiotherapy versus radiotherapy alone in the treatment of patients with locoregionally advanced nasopharyngeal carcinoma [ J]. Cancer, 1998,83 ( 11 ) : 2270- 2283.
  • 4Huncharek M, Kupelnick B. Combined chemoradiation versus radiation therapy alone in locally advanced nasopharyngeal carcinoma: results of a meta-analysis of 1,528 patients from six randomized trials[ J]. Am J Clin Oncol,2002,25 ( 3 ) :219-223.
  • 5Al-Sarraf M, Le Blanc M, Girl PG, et aL Chemoradiotherapy versus radiotherapy in patients with advanced nasopharyngeal cancer: phase Ⅲ randomized intergroup study 0099[J]. J Clin Oncol, 1998,16(4) :1310-1317.
  • 6Oh J, Vokes E, Kies M, et al. Induction chemotherapy followed by concomitant chemoradiotherapy for advanced nasopharyngeal cancer[ J]. Ann Oncol,2002,14(4) :565-569.
  • 7Johnson FM,Palmer JL. Kies M,et al. A phase II study of docetaxel and carboplatin as neoadjuvant therapy for nasopharyngeal carcinoma with early T status and advanced N status[ J]. Cancer,2004, 100(5) :991-998.
  • 8Rischin D, Corry J, Smith J, et al. Excellent disease control and survival in patients with advanced nasopharyngeal cancer treated with chemoradiation [J ]. J Clin Oncol,2002,20(7 ) : 1845-1852.
  • 9Chua DT, Ma J, Sham J. Long-term survival after cisplatin-based induction chemotherapy and radiotherapy for nasopharyngeal carcinoma:a pooled data analysis Of two phase Ⅲ trialS [ J ]. J Clin Oncol ,2005,23 (6) : 1118-1124.
  • 10Hareyama M, Sakata K, Shirato H, et al. A prospective, randomized trial comparing neoadjuvant chemotherapy with radiotherapy alone in patients with advanced nasopharyngeal carcinoma [ J ]. Cancer,2002:94( 8 ) :2217-2223.

引证文献1

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部